Efficacy and Safety of Ponatinib as a Second-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia: Retrospective Study at Two Japanese Centers

发表于 2026-9-11 11:39:55

期刊：Indian Journal of Hematology and Blood Transfusion

文献作者：Yoshimi Ishii; Shin Fujisawa; Katsumichi Fujimaki; Takuya Miyazaki; Yuki Nakajima; Yuto Hibino; Takaaki Takeda; Kosuke Takayama; Itaru Sato; Kota Kawabata; Hideaki Nakajima

出版日期：2026-9-

DOI号：10.1007/s12288-025-02301-7

下载链接：https://link.springer.com/conten ... 288-025-02301-7.pdf

文献链接：https://doi.org/10.1007/s12288-025-02301-7

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-9-11 11:39:56

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Springer] Efficacy and Safety of Ponatinib as a Second-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia: Retrospective Study at Two Japanese Centers

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Springer] Efficacy and Safety of Ponatinib as a Second-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia: Retrospective Study at Two Japanese Centers 一键复制

已采纳